Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00894985Phase 3Completed
A Phase 3 trial of heparin in cardiovascular diseases (CVD), sponsored by Azidus Laboratories Limited. Started Jun 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00894985.